
Royalty Pharma plc RPRX
$ 31.11
-2.14%
Annual report 2024
added 02-12-2025
Country |
![]() |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
448 M |
Market Cap[1] |
$ 13.9 B |
EBITDA (LTM) |
$ 1.1 B |
P/E (LTM) |
12.6 |
P/S (LTM) |
5.5 |
EPS (LTM) |
2.12 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.